Champions Oncology Q1 EPS $(0.16) Misses $(0.10) Estimate, Sales $12.60M Miss $13.06M Estimate
Portfolio Pulse from Benzinga Newsdesk
Champions Oncology (NASDAQ:CSBR) reported Q1 losses of $(0.16) per share, missing the analyst consensus estimate of $(0.10) by 60%. The company also reported quarterly sales of $12.60 million, missing the analyst consensus estimate of $13.06 million by 3.52%. This represents an 8.33% decrease over sales of $13.74 million the same period last year.
September 13, 2023 | 8:03 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Champions Oncology reported a larger than expected loss and lower sales for Q1, which could negatively impact its stock price.
Champions Oncology reported a larger than expected loss and lower sales for Q1. This underperformance compared to analyst estimates could lead to a decrease in investor confidence and a potential drop in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100